#Patientsafety

A new multicentre study found doctors became worse at spotting polyps after short-term AI exposure. The drop raises concern about rapid clinical dependence on AI-assisted tools (Lancet study) (PubMed abstract).

The study analysed colonoscopies at four Polish centres before and after AI introduction. The findings suggest real-world skill changes when clinicians rely on AI prompts (Lancet Gastroenterology & Hepatology study).

The study matters to Thai readers because colorectal screening saves lives. Thailand faces rising colorectal cancer rates that demand effective detection and trained doctors (Current Colorectal Cancer in Thailand).

A comprehensive multi-center study from Poland raises alarms about how brief exposure to AI-assisted colonoscopy may diminish physicians’ independent detection skills. The findings challenge the notion that AI automatically enhances care and prompt Thai health leaders to scrutinize how rapid AI integration could affect clinicians in screening programs.

In Thailand, colorectal cancer remains a major public health concern, accounting for a meaningful share of new cancer diagnoses. High-quality detection during colonoscopies is crucial for early treatment and better survival, making it essential to understand how AI tools influence physician performance, especially when AI is not actively guiding the procedure.

A recent international case of severe sepsis following an untreated urinary tract infection underscores a critical global warning. In Thailand, sepsis remains a major hospital and community challenge, making timely treatment and responsible antibiotic use more important than ever for patient safety.

Urinary tract infections affect millions worldwide each year and are especially common among women. In Thailand, UTIs impact working-age women and the elderly, with complications like sepsis possible when care is delayed or when antibiotic resistance reduces treatment effectiveness. Early, appropriate management is essential to prevent deterioration.

A recent medical case has sent an urgent warning across the world of public health: a British woman became a quadruple amputee after a simple urinary tract infection (UTI) went untreated and spiraled into life-threatening sepsis, underscoring both the frequency and the severity of this often underestimated medical condition. With over 15 million women affected by UTIs annually in the United States alone and nearly half of all women and over one in ten men experiencing a UTI in their lifetimes, the broader implications resonate globally, including in Thailand, where sepsis remains a persistent threat in hospitals and communities alike (Daily Mail).

A growing wave of premium medical travel is reshaping health tourism. Some wealthy patients are spending up to $60,000 for stem-cell injections at offshore clinics, chasing hope and relief even as experts warn about hype, safety gaps, and limited clinical validation. The trend, driven by hype and regulatory gaps, has drawn high-end travelers from tech hubs and professional sports to destinations in the Caribbean and Central America seeking exclusive therapies that remain restricted or unproven in the United States. Thailand, already a leading medical tourism hub, faces questions about how to balance opportunity with patient safety and scientific integrity.

Desperate for relief from pain and promising a chance to turn back the clock, affluent medical tourists are now spending up to $60,000 for unproven stem-cell injections in offshore clinics—a trend that experts warn is driven by hype, hope, and significant regulatory gaps. High-end patients from Silicon Valley and beyond are boarding flights to destinations like the Bahamas, Panama, and Costa Rica, seeking these exclusive therapies that remain illegal or tightly restricted in the United States due to safety concerns and a lack of clinical validation. This new “luxury medical tourism” is quickly becoming a global industry, raising major questions about risk, reward, and responsibility for Thailand, one of the world’s leading medical tourism hubs.

A U.S. FDA initiative with technology group OpenAI signals a potential shift in how medicines are evaluated. Early discussions center on AI-enabled review tools that could speed up drug assessment and influence global standards, a development watched closely in Thailand and across Asia.

For Thai readers, the possibility that AI could shorten approval times matters. Medicines today can take more than a decade to reach patients. If AI helps streamline this process in the United States, Thai regulators may feel pressure to explore similar tools, especially as Thailand positions itself as a medical hub for regional patients and innovators.

The US Food and Drug Administration (FDA) is engaging in active discussions with technology company OpenAI as part of a broader push to modernize drug evaluation with artificial intelligence. According to recent reporting by Wired, such collaboration could mark a pivotal shift in how new medicines are reviewed—potentially reducing the time it takes to bring life-saving drugs to market, and setting global trends that are closely watched in Thailand and across Asia Wired.

A life-threatening event after a newborn circumcision in a major New York hospital has drawn renewed attention to the risks of a procedure many consider routine. The incident, involving severe bleeding and organ stress, raises questions for Thai families and clinicians about safety, especially for babies with other medical conditions.

According to an investigative report, a baby boy with congenital heart issues faced serious complications shortly after circumcision. After initially appearing to recover well from heart-related interventions, the infant began bleeding heavily. Medical teams fought for hours to stop the hemorrhage, but the blood loss led to seizures, kidney and liver stress, and required multiple surgeries and blood transfusions. The episode underscores that, while rare, serious circumcision complications can occur, particularly in babies with underlying health concerns. In Thailand, where circumcision practices vary by religion and tradition, this case reinforces a vital message: routine does not always mean risk-free. Professional bodies such as the American College of Obstetricians and Gynecologists emphasize that possible complications include bleeding, infection, and, in very rare cases, more serious emergencies. Data from research databases shows that bleeding and injury are among the most common issues, with higher risk in infants with undetected clotting disorders or congenital conditions.

A newborn’s struggle for life following a circumcision “gone awry” at a leading New York medical center has sparked renewed scrutiny of the risks associated with a procedure widely considered routine. The case, which left the infant battling catastrophic bleeding, multiple organ failures, and significant trauma, has resurfaced critical questions for Thai families and health professionals about circumcision safety, especially for babies with underlying medical conditions.

According to an investigative report in The Independent, a baby boy born with congenital cardiac issues at New York-Presbyterian/Morgan Stanley Children’s Hospital suffered extensive complications hours after his circumcision. While initially deemed one of the healthiest infants in the neonatal intensive care unit following successful cardiac intervention, the infant’s fortunes turned after the standard surgical removal of his foreskin. Within hours, his diaper was found saturated with blood, urine, and stool, foreshadowing what would become a life-threatening cascade of medical crises (The Independent). Medical teams fought for hours to stanch the bleeding, but the scale of blood loss—equivalent to roughly half the infant’s total supply—prompted seizures, kidney and liver damage, and ultimately necessitated urgent transfusions and repeated surgical interventions to remove damaged sections of his intestines.

The latest research and expert commentary are bringing renewed attention to the hidden risks lurking within popular hair loss treatments—most notably the sexual side effects linked to medications like finasteride and dutasteride. Medical columns and international news outlets have recently spotlighted that while these drugs, which block the 5-alpha reductase enzyme and thus reduce dihydrotestosterone (DHT), remain effective for combating hair loss, they may also come with lingering consequences for men’s sexual health that are often underestimated by both patients and prescribers (The Detroit News).

Bradley Rhoton’s ordeal began with something most of us would ignore—a whistling sound in his nose while carving pumpkins for Halloween. But what started as harmless soon spiraled into a debilitating mystery. As The Washington Post recently reported, Rhoton, a Boston-based software marketer, underwent standard nasal surgery to correct a deviated septum and reduce the size of his nasal turbinates. Instead of breathing easy, he was left with crushing fatigue, constant congestion, sleep disturbances, anxiety, and a haze of brain fog that persisted for years. His frustrating journey through the healthcare system, marked by dismissals from multiple specialists, ultimately led to the little-known diagnosis of “empty nose syndrome” (ENS)—a rare but potentially devastating condition that paradoxically leaves patients feeling suffocated despite wide-open nasal passages (Washington Post; MSN News).

A whistling sound in the nose during Halloween carving sparked a medical mystery for a Boston software marketer. What began as a minor nuisance evolved into years of fatigue, congestion, sleep problems, anxiety, and brain fog. After seeking multiple opinions, he received a rarely discussed diagnosis: empty nose syndrome (ENS). This condition can leave patients feeling suffocated even when the nasal passages appear open.

For Thai readers, the case underscores a critical lesson: even routine procedures carry risks, and rare complications can have profound physical and psychological effects. In Thailand—where nasal and sinus issues are common due to allergies and urban pollution—turbinate reduction is frequently offered to relieve chronic congestion. International evidence suggests more patient education is needed to recognize and manage rare post-surgical syndromes like ENS.

A new report highlights a concerning truth for millions who reach for over-the-counter (OTC) painkillers: you’re probably using them incorrectly, putting your health at risk. Recent findings and expert advice, published by NPR on April 18, 2025, urge users of medicines like acetaminophen (Tylenol) and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin) and naproxen (Aleve), to rethink their habits to avoid accidental overdose and dangerous side effects [NPR].

A new report highlights a troubling reality for millions who reach for over-the-counter painkillers: many use them incorrectly, risking serious health problems. Recent findings and expert guidance urge users of medicines like acetaminophen and NSAIDs to reassess habits to prevent accidental overdose and dangerous side effects. Data and insights from NPR’s coverage emphasize why this matters for families across Thailand, where OTC medicines are widely available and often used without prescriptions.

Recent research has surfaced raising alarms about the use of gadolinium-based contrast agents (GBCAs) commonly administered during MRI scans. These agents, which enhance image accuracy, are pivotal in diagnosing various health conditions. However, the study suggests they could potentially lead to the formation of harmful substances within the body, a concern that warrants attention from healthcare providers and patients globally, including in Thailand where MRI diagnostics are routinely used.

Gadolinium, a rare earth metal, is usually safe in its chelated form used during MRIs. Yet, the new study highlights instances where gadolinium deposits could potentially form toxic materials when not adequately expelled from the body. This raises significant questions about long-term retention and the subsequent impact on health, particularly for patients undergoing multiple scans over extended periods.

New research raises questions about gadolinium-based contrast agents (GBCAs) used in MRI scans. These agents improve image clarity and help diagnose tumors, vascular issues, and other conditions. Yet emerging findings suggest gadolinium deposits could form toxic materials in the body if not fully expelled, prompting a careful review of safety practices for patients in Thailand and beyond.

Gadolinium is a rare earth metal. In MRI, it is given in a chelated form to reduce risk. The latest studies, however, highlight scenarios where gadolinium may accumulate if scans are repeated over time. This has implications for patients who undergo multiple MRIs, especially children and those with kidney concerns.